United States Biotechnology & Medical Research

Achaogen Inc (AKAOQ)

Track

Track

Ticker: AKAOQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.3
DUGGAN ROBERT W Large shareholder
Transaction date
Sale
Price
88.06
Quantity 37,632 +2.1%
Value US$2,271,573
4.3
DUGGAN ROBERT W Large shareholder
Transaction date
Sale
Price
349.54
Quantity 71,163 -7.3%
Value US$714,008
4.3
DUGGAN ROBERT W Large shareholder
Transaction date
Sale
Price
26.20
Quantity 75,371 +13.5%
Value US$3,769,323
4.3
DUGGAN ROBERT W Large shareholder
Transaction date
Sale
Price
0.59
Quantity 1,199,930 -14.9%
Value US$707,959
4.3
DUGGAN ROBERT W Large shareholder
Transaction date
Sale
Price
0.61
Quantity 633,975 -7.3%
Value US$386,725
4.3
DUGGAN ROBERT W Large shareholder
Transaction date
Sale
Price
0.63
Quantity 520,102 -5.7%
Value US$327,664
Bhatt Elizabeth Chief Operating Officer Officer
Transaction date
Sale
Price
0.89
Quantity 971 -0.4%
Value US$864
Dorling Janet Chief Commercial Officer Officer
Transaction date
Sale
Price
0.89
Quantity 1,063 -0.4%
Value US$946
Wise Blake Chief Executive Officer Officer
Transaction date
Sale
Price
0.89
Quantity 3,771 -0.7%
Value US$3,356
3.1
LOEB GARY See Remarks Officer
Transaction date
Sale
Price
0.89
Quantity 791 -0.3%
Value US$704
Sarpangal Zeryn Chief Financial Officer Officer
Transaction date
Sale
Price
0.89
Quantity 1,388 -0.6%
Value US$1,235
Dorling Janet Chief Commercial Officer Officer
Transaction date
Sale
Price
1.35
Quantity 818 -0.3%
Value US$1,104
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
1.65
Quantity 306,848 +3.5%
Value US$505,010
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 436,500 +5.2%
Value US$697,789
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
1.40
Quantity 22,431 +0.3%
Value US$31,394
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
1.68
Quantity 77,585 +0.9%
Value US$129,963
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
1.89
Quantity 80,175 +1.0%
Value US$151,643
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
1.93
Quantity 231,495 +2.9%
Value US$446,947
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
1.62
Quantity 4,648 +0.1%
Value US$7,525
LOEB GARY General Counsel Officer
Transaction date
Sale
Price
4.15
Quantity 1,038 -4.3%
Value US$4,308
Wise Blake Chief Operating Officer Officer
Transaction date
Sale
Price
4.15
Quantity 3,242 -3.4%
Value US$13,454
Dorling Janet Chief Commercial Officer
Transaction date
Planned sale
Price
9.59
Quantity 450 -1.9%
Value US$4,316
Wise Blake Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
9.59
Quantity 1,194 -1.2%
Value US$11,450
Hillan Kenneth J. See Remarks Executive Director
Transaction date
Planned sale
Price
9.59
Quantity 744 -0.6%
Value US$7,135
LOEB GARY General Counsel
Transaction date
Planned sale
Price
9.59
Quantity 324 -1.3%
Value US$3,107
Schilke Tobin Chief Financial Officer
Transaction date
Sale
Price
9.59
Quantity 298 -0.6%
Value US$2,858
Schilke Tobin Chief Financial Officer
Transaction date
Planned sale
Price
11.95
Quantity 2,087 -4.2%
Value US$24,940
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.43
Quantity 100,255 +inf%
Value US$1,146,316
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.54
Quantity 30,000 +inf%
Value US$346,338
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.31
Quantity 846,625 +11.8%
Value US$9,579,477
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
12.96
Quantity 102,849 +1.5%
Value US$1,333,160
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
12.96
Quantity 50,000 +0.7%
Value US$647,755
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
13.02
Quantity 77,247 +1.1%
Value US$1,005,949
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
13.07
Quantity 132,487 +1.9%
Value US$1,730,969
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
13.23
Quantity 216,150 +3.3%
Value US$2,860,421
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
12.76
Quantity 119,700 +1.8%
Value US$1,527,264
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
12.44
Quantity 47,361 +0.7%
Value US$588,977
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
12.46
Quantity 24,100 +0.4%
Value US$300,240
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
12.51
Quantity 20,000 +0.3%
Value US$250,202
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
12.44
Quantity 30,000 +0.5%
Value US$373,095
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.09
Quantity 25,000 +0.4%
Value US$277,155
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.20
Quantity 11,300 +0.2%
Value US$126,557
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.23
Quantity 30,000 +0.5%
Value US$336,756
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.57
Quantity 19,660 +0.3%
Value US$227,488
Hillan Kenneth J. See Remarks Executive Director
Transaction date
Sale
Price
11.74
Quantity 2,735 -2.8%
Value US$32,109
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.39
Quantity 20,000 +0.3%
Value US$227,802
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.41
Quantity 50,000 +0.8%
Value US$570,520
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
10.14
Quantity 96,790 +1.6%
Value US$981,683
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
10.33
Quantity 410,606 +7.2%
Value US$4,243,285
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
10.70
Quantity 20,000 +0.4%
Value US$213,928
Wise Blake Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
10.67
Quantity 1,640 -2.4%
Value US$17,499
3.8
Schilke Tobin Chief Financial Officer Officer
Transaction date
Planned sale
Price
10.67
Quantity 1,108 -2.7%
Value US$11,822
Swem Lee Chief Scientific Officer Officer
Transaction date
Planned sale
Price
10.67
Quantity 1,282 -3.4%
Value US$13,679
Hillan Kenneth J. See Remarks Executive Director
Transaction date
Planned sale
Price
10.67
Quantity 4,606 -4.5%
Value US$49,146
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
10.96
Quantity 9,442 +0.2%
Value US$103,487
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
10.97
Quantity 558 +0.0%
Value US$6,119
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.51
Quantity 50,000 +0.9%
Value US$575,500
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
10.89
Quantity 15,000 +0.3%
Value US$163,353
DUGGAN ROBERT W Large shareholder
Transaction date
Purchase
Price
11.13
Quantity 95,012 +1.7%
Value US$1,057,493
LOEB GARY General Counsel
Transaction date
Sale
Price
15.99
Quantity 1,146 -7.9%
Value US$18,325
Wise Blake President & COO
Transaction date
Sale
Price
15.99
Quantity 3,576 -5.1%
Value US$57,180
Swem Lee Chief Scientific Officer Officer
Transaction date
Sale
Price
15.99
Quantity 900 -2.4%
Value US$14,391
3.8
Schilke Tobin Chief Financial Officer
Transaction date
Planned sale
Price
21.53
Quantity 2,066 -4.9%
Value US$44,481
Hillan Kenneth J. Chief Executive Officer Executive Director
Transaction date
Sale
Price
26.58
Quantity 3,079 -3.0%
Value US$81,840
Sarpangal Zeryn See Remarks
Transaction date
Sale
Price
22.76
Quantity 439 -2.6%
Value US$9,992
Friedland Ian SVP, Chief Medical Officer
Transaction date
Sale
Price
22.76
Quantity 1,026 -2.7%
Value US$23,352
Hillan Kenneth J. Chief Executive Officer Executive Director
Transaction date
Sale
Price
22.76
Quantity 1,696 -2.7%
Value US$38,601
Hillan Kenneth J. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
16.78
Quantity 1,431 -2.2%
Value US$24,012
Friedland Ian Chief Medical Officer
Transaction date
Planned sale
Price
16.78
Quantity 695 -1.8%
Value US$11,662
Wise Blake Chief Operating Officer
Transaction date
Planned sale
Price
16.78
Quantity 1,431 -3.0%
Value US$24,012
Sarpangal Zeryn VP, HR and Corporate Affairs
Transaction date
Sale
Price
16.78
Quantity 781 -4.4%
Value US$13,105
LOEB GARY General Counsel
Transaction date
Sale
Price
16.78
Quantity 521 -3.5%
Value US$8,742
Schilke Tobin Chief Financial Officer
Transaction date
Sale
Price
16.78
Quantity 955 -3.5%
Value US$16,025
MOTT DAVID M Large shareholder
Transaction date
Purchase
Price
13.50
Quantity 500,000 +10.6%
Value US$6,750,000
Sonsini Peter W. Large shareholder
Transaction date
Purchase
Price
13.50
Quantity 500,000 +10.6%
Value US$6,750,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-03-20 2019-03-20 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
37,632 +2.1%
88.06
US$2,271,573 		37,632 +2.1% 88.06 US$2,271,573
2019-03-20 2019-03-19 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
71,163 -7.3%
349.54
US$714,008 		71,163 -7.3% 349.54 US$714,008
2019-03-20 2019-03-18 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
75,371 +13.5%
26.20
US$3,769,323 		75,371 +13.5% 26.20 US$3,769,323
2019-03-13 2019-03-13 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
1,199,930 -14.9%
0.59
US$707,959 		1,199,930 -14.9% 0.59 US$707,959
2019-03-13 2019-03-12 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
633,975 -7.3%
0.61
US$386,725 		633,975 -7.3% 0.61 US$386,725
2019-03-13 2019-03-11 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
520,102 -5.7%
0.63
US$327,664 		520,102 -5.7% 0.63 US$327,664
2019-02-25 2019-02-21 S Sale
Bhatt Elizabeth

Chief Operating Officer

Officer
971 -0.4%
0.89
US$864 		971 -0.4% 0.89 US$864
2019-02-25 2019-02-21 S Sale
Dorling Janet

Chief Commercial Officer

Officer
1,063 -0.4%
0.89
US$946 		1,063 -0.4% 0.89 US$946
2019-02-25 2019-02-21 S Sale
Wise Blake

Chief Executive Officer

Officer
3,771 -0.7%
0.89
US$3,356 		3,771 -0.7% 0.89 US$3,356
2019-02-25 2019-02-21 S Sale
3.1
LOEB GARY

See Remarks

Officer
791 -0.3%
0.89
US$704 		791 -0.3% 0.89 US$704
2019-02-25 2019-02-21 S Sale
Sarpangal Zeryn

Chief Financial Officer

Officer
1,388 -0.6%
0.89
US$1,235 		1,388 -0.6% 0.89 US$1,235
2019-02-07 2019-02-05 S Sale
Dorling Janet

Chief Commercial Officer

Officer
818 -0.3%
1.35
US$1,104 		818 -0.3% 1.35 US$1,104
2018-12-12 2018-12-11 B Purchase DUGGAN ROBERT W Large shareholder
306,848 +3.5%
1.65
US$505,010 		306,848 +3.5% 1.65 US$505,010
2018-12-12 2018-12-10 B Purchase DUGGAN ROBERT W Large shareholder
436,500 +5.2%
1.60
US$697,789 		436,500 +5.2% 1.60 US$697,789
2018-12-11 2018-12-07 B Purchase DUGGAN ROBERT W Large shareholder
22,431 +0.3%
1.40
US$31,394 		22,431 +0.3% 1.40 US$31,394
2018-11-27 2018-11-27 B Purchase DUGGAN ROBERT W Large shareholder
77,585 +0.9%
1.68
US$129,963 		77,585 +0.9% 1.68 US$129,963
2018-11-27 2018-11-23 B Purchase DUGGAN ROBERT W Large shareholder
80,175 +1.0%
1.89
US$151,643 		80,175 +1.0% 1.89 US$151,643
2018-11-23 2018-11-20 B Purchase DUGGAN ROBERT W Large shareholder
231,495 +2.9%
1.93
US$446,947 		231,495 +2.9% 1.93 US$446,947
2018-11-20 2018-11-19 B Purchase DUGGAN ROBERT W Large shareholder
4,648 +0.1%
1.62
US$7,525 		4,648 +0.1% 1.62 US$7,525
2018-09-27 2018-09-25 S Sale
LOEB GARY

General Counsel

Officer
1,038 -4.3%
4.15
US$4,308 		1,038 -4.3% 4.15 US$4,308
2018-09-27 2018-09-25 S Sale Wise Blake

Chief Operating Officer

Officer
3,242 -3.4%
4.15
US$13,454 		3,242 -3.4% 4.15 US$13,454
2018-06-28 2018-06-26 PlS Planned sale
Dorling Janet

Chief Commercial Officer
450 -1.9%
9.59
US$4,316 		450 -1.9% 9.59 US$4,316
2018-06-28 2018-06-26 PlS Planned sale Wise Blake

Chief Executive Officer

Executive Director
1,194 -1.2%
9.59
US$11,450 		1,194 -1.2% 9.59 US$11,450
2018-06-28 2018-06-26 PlS Planned sale
Hillan Kenneth J.

See Remarks

Executive Director
744 -0.6%
9.59
US$7,135 		744 -0.6% 9.59 US$7,135
2018-06-28 2018-06-26 PlS Planned sale LOEB GARY

General Counsel
324 -1.3%
9.59
US$3,107 		324 -1.3% 9.59 US$3,107
2018-06-28 2018-06-26 S Sale Schilke Tobin

Chief Financial Officer
298 -0.6%
9.59
US$2,858 		298 -0.6% 9.59 US$2,858
2018-06-13 2018-06-11 PlS Planned sale Schilke Tobin

Chief Financial Officer
2,087 -4.2%
11.95
US$24,940 		2,087 -4.2% 11.95 US$24,940
2018-05-07 2018-05-03 B Purchase DUGGAN ROBERT W Large shareholder
100,255 +inf%
11.43
US$1,146,316 		100,255 +inf% 11.43 US$1,146,316
2018-05-07 2018-05-03 B Purchase DUGGAN ROBERT W Large shareholder
30,000 +inf%
11.54
US$346,338 		30,000 +inf% 11.54 US$346,338
2018-05-07 2018-05-03 B Purchase DUGGAN ROBERT W Large shareholder
846,625 +11.8%
11.31
US$9,579,477 		846,625 +11.8% 11.31 US$9,579,477
2018-04-27 2018-04-27 B Purchase DUGGAN ROBERT W Large shareholder
102,849 +1.5%
12.96
US$1,333,160 		102,849 +1.5% 12.96 US$1,333,160
2018-04-27 2018-04-26 B Purchase DUGGAN ROBERT W Large shareholder
50,000 +0.7%
12.96
US$647,755 		50,000 +0.7% 12.96 US$647,755
2018-04-27 2018-04-25 B Purchase DUGGAN ROBERT W Large shareholder
77,247 +1.1%
13.02
US$1,005,949 		77,247 +1.1% 13.02 US$1,005,949
2018-04-23 2018-04-23 B Purchase DUGGAN ROBERT W Large shareholder
132,487 +1.9%
13.07
US$1,730,969 		132,487 +1.9% 13.07 US$1,730,969
2018-04-23 2018-04-20 B Purchase DUGGAN ROBERT W Large shareholder
216,150 +3.3%
13.23
US$2,860,421 		216,150 +3.3% 13.23 US$2,860,421
2018-04-23 2018-04-19 B Purchase DUGGAN ROBERT W Large shareholder
119,700 +1.8%
12.76
US$1,527,264 		119,700 +1.8% 12.76 US$1,527,264
2018-04-04 2018-04-04 B Purchase DUGGAN ROBERT W Large shareholder
47,361 +0.7%
12.44
US$588,977 		47,361 +0.7% 12.44 US$588,977
2018-04-04 2018-04-03 B Purchase DUGGAN ROBERT W Large shareholder
24,100 +0.4%
12.46
US$300,240 		24,100 +0.4% 12.46 US$300,240
2018-04-04 2018-04-02 B Purchase DUGGAN ROBERT W Large shareholder
20,000 +0.3%
12.51
US$250,202 		20,000 +0.3% 12.51 US$250,202
2018-03-30 2018-03-28 B Purchase DUGGAN ROBERT W Large shareholder
30,000 +0.5%
12.44
US$373,095 		30,000 +0.5% 12.44 US$373,095
2018-03-21 2018-03-20 B Purchase DUGGAN ROBERT W Large shareholder
25,000 +0.4%
11.09
US$277,155 		25,000 +0.4% 11.09 US$277,155
2018-03-21 2018-03-19 B Purchase DUGGAN ROBERT W Large shareholder
11,300 +0.2%
11.20
US$126,557 		11,300 +0.2% 11.20 US$126,557
2018-03-16 2018-03-15 B Purchase DUGGAN ROBERT W Large shareholder
30,000 +0.5%
11.23
US$336,756 		30,000 +0.5% 11.23 US$336,756
2018-03-16 2018-03-14 B Purchase DUGGAN ROBERT W Large shareholder
19,660 +0.3%
11.57
US$227,488 		19,660 +0.3% 11.57 US$227,488
2018-03-15 2018-03-13 S Sale Hillan Kenneth J.

See Remarks

Executive Director
2,735 -2.8%
11.74
US$32,109 		2,735 -2.8% 11.74 US$32,109
2018-03-13 2018-03-12 B Purchase DUGGAN ROBERT W Large shareholder
20,000 +0.3%
11.39
US$227,802 		20,000 +0.3% 11.39 US$227,802
2018-03-13 2018-03-09 B Purchase DUGGAN ROBERT W Large shareholder
50,000 +0.8%
11.41
US$570,520 		50,000 +0.8% 11.41 US$570,520
2018-03-02 2018-03-02 B Purchase DUGGAN ROBERT W Large shareholder
96,790 +1.6%
10.14
US$981,683 		96,790 +1.6% 10.14 US$981,683
2018-03-02 2018-03-01 B Purchase DUGGAN ROBERT W Large shareholder
410,606 +7.2%
10.33
US$4,243,285 		410,606 +7.2% 10.33 US$4,243,285
2018-03-02 2018-02-28 B Purchase DUGGAN ROBERT W Large shareholder
20,000 +0.4%
10.70
US$213,928 		20,000 +0.4% 10.70 US$213,928
2018-02-23 2018-02-21 PlS Planned sale
Wise Blake

Chief Executive Officer

Executive Director
1,640 -2.4%
10.67
US$17,499 		1,640 -2.4% 10.67 US$17,499
2018-02-23 2018-02-21 PlS Planned sale
3.8
Schilke Tobin

Chief Financial Officer

Officer
1,108 -2.7%
10.67
US$11,822 		1,108 -2.7% 10.67 US$11,822
2018-02-23 2018-02-21 PlS Planned sale Swem Lee

Chief Scientific Officer

Officer
1,282 -3.4%
10.67
US$13,679 		1,282 -3.4% 10.67 US$13,679
2018-02-23 2018-02-21 PlS Planned sale Hillan Kenneth J.

See Remarks

Executive Director
4,606 -4.5%
10.67
US$49,146 		4,606 -4.5% 10.67 US$49,146
2018-02-15 2018-02-14 B Purchase DUGGAN ROBERT W Large shareholder
9,442 +0.2%
10.96
US$103,487 		9,442 +0.2% 10.96 US$103,487
2018-02-15 2018-02-13 B Purchase DUGGAN ROBERT W Large shareholder
558 +0.0%
10.97
US$6,119 		558 +0.0% 10.97 US$6,119
2018-01-05 2018-01-05 B Purchase DUGGAN ROBERT W Large shareholder
50,000 +0.9%
11.51
US$575,500 		50,000 +0.9% 11.51 US$575,500
2018-01-05 2018-01-03 B Purchase DUGGAN ROBERT W Large shareholder
15,000 +0.3%
10.89
US$163,353 		15,000 +0.3% 10.89 US$163,353
2017-12-20 2017-12-18 B Purchase DUGGAN ROBERT W Large shareholder
95,012 +1.7%
11.13
US$1,057,493 		95,012 +1.7% 11.13 US$1,057,493
2017-09-28 2017-09-26 S Sale
LOEB GARY

General Counsel
1,146 -7.9%
15.99
US$18,325 		1,146 -7.9% 15.99 US$18,325
2017-09-28 2017-09-26 S Sale
Wise Blake

President & COO
3,576 -5.1%
15.99
US$57,180 		3,576 -5.1% 15.99 US$57,180
2018-05-15 2017-09-25 S Sale Swem Lee

Chief Scientific Officer

Officer
900 -2.4%
15.99
US$14,391 		900 -2.4% 15.99 US$14,391
2017-06-14 2017-06-12 PlS Planned sale
3.8
Schilke Tobin

Chief Financial Officer
2,066 -4.9%
21.53
US$44,481 		2,066 -4.9% 21.53 US$44,481
2017-03-16 2017-03-14 S Sale
Hillan Kenneth J.

Chief Executive Officer

Executive Director
3,079 -3.0%
26.58
US$81,840 		3,079 -3.0% 26.58 US$81,840
2017-02-23 2017-02-21 S Sale Sarpangal Zeryn

See Remarks
439 -2.6%
22.76
US$9,992 		439 -2.6% 22.76 US$9,992
2017-02-23 2017-02-21 S Sale Friedland Ian

SVP, Chief Medical Officer
1,026 -2.7%
22.76
US$23,352 		1,026 -2.7% 22.76 US$23,352
2017-02-23 2017-02-21 S Sale
Hillan Kenneth J.

Chief Executive Officer

Executive Director
1,696 -2.7%
22.76
US$38,601 		1,696 -2.7% 22.76 US$38,601
2017-01-30 2017-01-26 PlS Planned sale
Hillan Kenneth J.

Chief Executive Officer

Executive Director
1,431 -2.2%
16.78
US$24,012 		1,431 -2.2% 16.78 US$24,012
2017-01-30 2017-01-26 PlS Planned sale Friedland Ian

Chief Medical Officer
695 -1.8%
16.78
US$11,662 		695 -1.8% 16.78 US$11,662
2017-01-30 2017-01-26 PlS Planned sale
Wise Blake

Chief Operating Officer
1,431 -3.0%
16.78
US$24,012 		1,431 -3.0% 16.78 US$24,012
2017-01-30 2017-01-26 S Sale
Sarpangal Zeryn

VP, HR and Corporate Affairs
781 -4.4%
16.78
US$13,105 		781 -4.4% 16.78 US$13,105
2017-01-30 2017-01-26 S Sale
LOEB GARY

General Counsel
521 -3.5%
16.78
US$8,742 		521 -3.5% 16.78 US$8,742
2017-01-30 2017-01-26 S Sale Schilke Tobin

Chief Financial Officer
955 -3.5%
16.78
US$16,025 		955 -3.5% 16.78 US$16,025
2016-12-19 2016-12-19 B Purchase MOTT DAVID M Large shareholder
500,000 +10.6%
13.50
US$6,750,000 		500,000 +10.6% 13.50 US$6,750,000
2016-12-19 2016-12-19 B Purchase Sonsini Peter W. Large shareholder
500,000 +10.6%
13.50
US$6,750,000 		500,000 +10.6% 13.50 US$6,750,000
Explore more

More insider trading research around Achaogen Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America